Vimarsana
Biggest News Aggregation in the World

Page 3 - Intersect Ent Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Intersect Ent Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Intersect Ent Inc Today - Breaking & Trending Today

GT Newsletter | Competition Currents | June 2022 | Insights - Vimarsana News

GT Newsletter | Competition Currents | June 2022 | Insights

Welcome to Competition Currents, a monthly newsletter for Greenberg Traurig clients and colleagues highlighting significant recent developments in global antitrust and competition law.

Source: gtlaw.com
Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com - Vimarsana News

Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the medical equipment provider’s stock. Intersect ENT stock opened at $28.24 on Friday. The stock has a 50-day moving average of $28.03 and a two-hundred day moving average […]

Global Competition Currents June 2022 Update - Vimarsana News

Global Competition Currents June 2022 Update

Federal Trade Commission (FTC), Department of Justice (DOJ), U.S. Litigation, Dutch ACM decisions, policies, and market studies, Dutch Courts, UK State of Competition, Antitrust enforcement, Antitrust litigation, Mergers

Financial Contrast: LMF Acquisition Opportunities (NASDAQ:LMAO) versus Intersect ENT (NASDAQ:XENT) - Vimarsana News

Financial Contrast: LMF Acquisition Opportunities (NASDAQ:LMAO) versus Intersect ENT (NASDAQ:XENT)

Intersect ENT (NASDAQ:XENT – Get Rating) and LMF Acquisition Opportunities (NASDAQ:LMAO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, institutional ownership, dividends, analyst recommendations, risk and earnings. Profitability This table compares Intersect ENT and LMF […]

Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com - Vimarsana News

Intersect ENT (NASDAQ:XENT) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Intersect ENT (NASDAQ:XENT – Get Rating) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the medical equipment provider’s stock. Shares of NASDAQ:XENT opened at $28.24 on Thursday. The firm’s 50 day moving average is $27.99 and its two-hundred day moving average is […]